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Background: Parvovirus B19 (B19V) genome was associated with dilated cardiomyopathy (DCM) and ventricular diastolic dysfunction without 
amyloidosis. Using electron microscopy (EM) we observed amyloid fibrils in cardiomyopathies without histological amyloidosis. Here we tested the 
hypothesis that B19V infection is associated with amyloidosis or cardiomyopathies presenting amyloid fibrils.
Methods: Endomyocardial biopsies of patients with suspected myocarditis/ restrictive cardiomyopathy or DCM, from two Institutions, were studied 
for B19V and amyloid fibrils with different techniques: a) in 17 cases from the Heart Institute of São Paulo University, Brazil, B19V antigen was 
analyzed by immunohistochemistry (IHC) and in situ hybridization (ISH) techniques, amyloid fibrils by EM; b) in 7 cases from Charité -University 
Medicine Berlin, Germany, B19V was analyzed by PCR, IHC and ISH, and amyloid by biochemical analysis. Viruses at IHC or ISH and amyloid fibrils at 
EM were semi-quantified as 0 (absent), + (scarce), ++ (moderate and multifocal) and +++ (intense and difuse).
Results: G1 - amyloid negative group (12 cases) included 7 lymphocytic myocarditis, 4 borderline myocarditis and 1 DCM; G2 - amyloid positive 
group (12 cases) 1 mild myocarditis, 1 borderline myocarditis, 2 DCM and 8 amyloidosis. There was a significantly higher amount of B19V (detected 
by one of the techniques) in G2 than in G1 (92% vs 50% respectively, P<0.05). 8 of the 9 amyloidosis cases were positive for B19V. Intense or 
moderate numbers of B19V antigens or DNA were present in 58% of G2, and in 17% of G1. Cases with ++ or +++ of B19V, the antigens were usually 
seen both in inflammatory cells and surrounded myocardial fibers. ISH and IHC provided similar results, indicating the reliability of these techniques. 
Conclusions: Cardiac amyloidosis was associated with a high incidence of B19V infection, as were DCM or lymphocytic myocarditis presenting 
amyloid fibrils detected by EM. Amyloid fibrils could be a cause of diastolic ventricular dysfunction in the latter patients, however the clinical 
significance of these initial findings needs further studies.
